Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphoma, B-Cell × Dexamethasone × Clear all

Phase

Phase 1 3 Phase 1/2 2 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 294 Neoplasms, Plasma Cell 52 Precursor Cell Lymphoblastic Leukemia-Lymphoma 44 Recurrence 40 Lymphoma 39 Leukemia 33 Burkitt Lymphoma 23 Lymphoma, Mantle-Cell 22 Neoplasms 21 Waldenstrom Macroglobulinemia 20 Immunoglobulin Light-chain Amyloidosis 20 Lymphoma, Large B-Cell, Diffuse 18 Lymphoma, Non-Hodgkin 17 Lymphoma, Follicular 16 Leukemia, Lymphocytic, Chronic, B-Cell 14 Lymphoma, Extranodal NK-T-Cell 11 Hodgkin Disease 11 Prostatic Neoplasms 10 Lymphoma, B-Cell, Marginal Zone 10 Breast Neoplasms 10 Vomiting 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9 Smoldering Multiple Myeloma 8 Renal Insufficiency 8 Lymphoma, Large-Cell, Immunoblastic 8 Neoplasm Metastasis 7 Nausea 7 Lung Neoplasms 7 Leukemia, Biphenotypic, Acute 6 Carcinoma, Non-Small-Cell Lung 6

Interventions

Rituximab 35 Cyclophosphamide 28 Doxorubicin 13 Prednisone 12 fludarabine 11 Vincristine 10 Etoposide 10 ibrutinib 8 Bortezomib 7 pembrolizumab 6 Mycophenolic Acid 6 Magnetic Resonance Spectroscopy 6 Lenalidomide 6 Specimen Handling 5 Immunotherapy, Adoptive 5 CT-P10 5 polatuzumab vedotin 4 fludarabine phosphate 4 Vorinostat 4 Nivolumab 4 Ifosfamide 4 Cytarabine 4 Carboplatin 4 obinutuzumab 3 Whole-Body Irradiation 3 Tacrolimus 3 Radiotherapy 3 Gemcitabine 3 Filgrastim 3 Cyclosporine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00413959 2018-09-19

VRCD

Oncology Specialists, S.C.

Phase 2 Terminated

12 enrolled 7 charts

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡